ID   GCSR1
AC   CVCL_HF51
SY   GCSR-1
DR   cancercelllines; CVCL_HF51
DR   Wikidata; Q54835511
RX   PubMed=25892440;
CC   Population: Chinese.
CC   Doubling time: ~67.65 hours (PubMed=25892440).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=25892440).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
RX   PubMed=25892440; DOI=10.3892/ijo.2015.2966;
RA   Xu X., Qian L.-J., Su X.-Y., He K.-F., Jin K.-T., Gu L.-H., Feng J.-G.,
RA   Li G.-L., Zhou Q., Xu Z.-Z., Wang H.-H., Zhang J., Cao J., Teng L.-S.;
RT   "Establishment and characterization of GCSR1, a multi-drug resistant
RT   signet ring cell gastric cancer cell line.";
RL   Int. J. Oncol. 46:2479-2487(2015).
//